Alfaxalone

This classification denotes an anesthetic agent with the molecular formula C21H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BD07M97B2A, chemically known as 5-alpha-pregnane-11,20-dione, 3-alpha-hydroxy- but generally known as alfaxalone, which bears US NIH Compound Identifier 104845. European Medicines Agency schedules Alfaxalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05316MIG. The term ALFAXALONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules alfaxalone in its Anatomical Therapeutic Chemical (ATC) Classification. ALFAXALONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alfaxalone under HS 29144090 and SITC 51629. As of Q4 2014, ALFAXALONE remains the US FDA Preferred Term for this commodity. Alfaxalone bears US NLM identifiers UMLS ID C0051482 and NCI Concept Code C72161. SMILES: O=C1C2C(C3C(C(CC3)C(=O)C)(C1)C)CCC1C2(CCC(O)C1)C.